The U.S. is halting the reopening of the economy as Coronavirus cases hit record highs, stimulus money is running out and we don’t seem to be any closer to a vaccine or accurate testing…
Market conditions are eerily similar to right before the first outbreak of the pandemic…
Due to the times we find ourselves in, we wanted to give our followers some great stocks that we like the look of. Stocks that have performed well before and during COVID-19 and stocks we see with great momentum on their side.
The market has priced-in the demand for motorhomes as people are looking to get-away from the COVID-19 mess and look to take vacations inside their own confines. The world’s largest recreational vehicles (RV) manufacturer, Thor, has seen through-the-roof sales to satisfy customers RV demands.
TAKE-TWO INTERACTIVE SOFTWARE, INC (NASDAQ:TTWO)
Sporting events are off, people staying at home and spending their time and money on video games… 5G is making Virtual Reality possible… All good news for the video game industry and Take-Two Interactive. The company has beaten earnings expectations for the last 4 quarters and with the pandemic still very much on, this stock could look poised to continue the momentum.
Demand for pets has been at an all-time-high during the Coronavirus pandemic… Animal shelters across the U.S. have been empty of all pets… The pet industry has been very hot even as markets decline. Trupanion has a subscription model for pet insurance and pet care with a reliable cash flow. The company reported a quarterly revenue of $111.3 million and subscription enrolment is up 25% from a year ago.
Another stock benefiting from the surge in the pet industry is IDEXX Labs. They primary business model is pet software diagnostics. The company reported a profit of $359.59 million and saw revenue increase to $626.34 million. IDEXX Labs annual income has been growing 20% annually for the last 5 years.
Watch the full interview for in-depth analysis on these names and a comprehensive breakdown of markets/economy in these unprecedented times.
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.